相关实验视频

Updated: May 23, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

脑瘤中的表观遗传重编程和抗瘤免疫反应:系统性审查

Fathima Raahima Riyas Mohamed¹, Ahmed Yaqinuddin²

¹College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

Medical oncology (Northwood, London, England)

|May 16, 2025

概括

表观遗传疗法重编程质瘤微环境,以增强抗瘤免疫力. 这些治疗方法,包括DNA甲基化抑制剂和基因素脱乙酶抑制剂,在克服治疗耐药性和改善生存率方面表现有前途.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

质瘤,特别是质母细胞瘤,是具有不良治疗结果的侵袭性脑瘤.
它们的免疫抑制性瘤微环境和分子异质性阻碍了治疗疗效.
表观遗传失调驱动着质瘤的进展和免疫逃避,提供了一个治疗点.

研究的目的:

系统地审查表观遗传重编程在质瘤中调节抗瘤免疫力的作用.
探索表观遗传疗法的潜力,以提高质瘤患者的治疗结果.

主要方法:

系统的文献审查遵循PRISMA指南.
包括表观遗传疗法 (DNA甲基化抑制剂,HDAC抑制剂,染色质重塑剂,ncRNA疗法) 的临床前和临床研究.
对结果的分析包括免疫激活,瘤进展,存活率和TME调节.

主要成果:

表观遗传疗法有效地重新编程了质瘤免疫格局.
DNA甲基化抑制剂增强了抗原呈现;HDAC抑制剂改善了T细胞细胞毒性.
非编码RNA疗法破坏了免疫抑制,促进了免疫细胞的透.
与免疫检查点抑制剂的协同作用导致瘤生长抑制,并在临床前模型中改善了生存率.

结论:

表观遗传疗法对克服质瘤诱导的免疫抵抗有显著的前景.
调节免疫逃生机制和重编程瘤微环境是关键的好处.
与免疫疗法的整合为质瘤管理提供了一种变革性的方法,需要进一步的临床验证.

关键词:

通过DNA甲基化.表观遗传重编程是一种表观遗传重编程.质母细胞瘤多形质瘤是一种质瘤.基因组胺基因的修改

更多相关视频

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections

Published on: July 31, 2017

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

相关概念视频

Somatic to iPS Cell Reprogramming

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...

Methods of Nuclear Reprogramming

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.